Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

297.19
Delayed Data
As of Dec 02
 +1.41 / +0.48%
Today’s Change
223.02
Today|||52-Week Range
333.65
-2.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Operating ActivitiesNet Income / Starting Line828.7M969.2M1.0B1.0B
 
 
 
 
 
Depreciation156.3M149.7M175.4M180.2M
 
 
 
 
 
Total Other Cash Flow80.5M25.1M78.8M47.3M
 
 
 
 
 
Funds From Operations1.1B1.2B1.3B1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses65.3M189.5M267.7M244.5M
 
 
 
 
 
Net Cash Flow - Operating Activities1.0B963.4M995.8M986.6M
 
 
 
 
 
 
InvestingIncrease In Investments-2.0B-1.9B-1.9B-1.8B
 
 
 
 
 
Decrease In Investments699.6M1.2B1.6B2.4B
 
 
 
 
 
Capital Expenditures-186.1M-126.9M-136.8M-170.3M
 
 
 
 
 
Net Assets From Acquisitions -2.0K0.000.000.00
 
 
Other Investing - Uses-326.3M-343.0M-322.9M-246.9M
 
 
 
 
 
Net Cash Flow Investing-1.8B-1.2B-736.1M36.2M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings-436.0K------
 
 
Long Term Debt Reduction-17.0K------
 
 
Net Proceeds Stock Sale8.7M14.5M9.4M11.3M
 
 
 
 
 
Common Preferred Redeemed-2.0B0.000.00-348.9M
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing7.4M32.9M-22.8M39.7M
 
 
 
 
 
Other Uses - Financing12.3M0.000.000.00
 
 
Net Cash Flow - Financing-2.0B47.4M-13.4M-300.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-15.4M15.1M-15.0M600.0K
 
 
 
 
 
 
Net Change In Cash-2.8B-192.4M246.3M722.2M